Circulating Retinol-Binding Protein 4 as a Possible Biomarker of Treatment Response for Ankylosing Spondylitis: An Array-Based Comparative Study.

导出 LinkOut

翻译打印收藏纠错

第一作者： Jialing,Wu

第一单位： Department of Rheumatology and Immunology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.

作者： Jialing,Wu ^[1] ; Xinyu,Wu ^[1] ; Zena,Chen ^[1] ; Qing,Lv ^[1] ; Mingcan,Yang ^[1] ; Xuqi,Zheng ^[1] ; Qiuxia,Li ^[1] ; Yanli,Zhang ^[1] ; Qiujing,Wei ^[1] ; Shuangyan,Cao ^[1] ; Xiaomin,Li ^[1] ; Jun,Qi ^[1] ; Minjing,Zhao ^[1] ; Zetao,Liao ^[1] ; Zhiming,Lin ^[1] ; Jieruo,Gu ^[1]

作者单位： Department of Rheumatology and Immunology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China. ^[1]

关键词 adalimumab ankylosing spondylitis biomarker protein arrays retinol-binding protein 4

DOI 10.3389/fphar.2020.00231

PMID 32210816

发布时间 2022-04-13

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Frontiers in pharmacology

2020年11卷

231页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Circulating Retinol-Binding Protein 4 as a Possible Biomarker of Treatment Response for Ankylosing Spondylitis: An Array-Based Comparative Study.

Frontiers in pharmacology

相似文献

Frontiers in pharmacology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Circulating Retinol-Binding Protein 4 as a Possible Biomarker of Treatment Response for Ankylosing Spondylitis: An Array-Based Comparative Study.

Frontiers in pharmacology

相似文献

Frontiers in pharmacology

相关期刊

检索历史清除